Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and 123I for localization of rapid washout parathyroid adenomas
- 28 Downloads
Tc99m-sestamibi dual-time imaging is a standard tool for localization of adenomas/hyperplasia in hyperparathyroidism. We investigated the degree and causes of localization failure among different types of hyperparathyroidism. Pre-operative parathyroid hormone levels and size of the gland were major determinants of Tc99m-sestamibi positivity; 123I scan may be helpful in localization failures.
Tc99m-sestamibi dual-time imaging is a standard tool for localization of adenomas/hyperplasia in hyperparathyroidism. However, parathyroid adenomas/hyperplasia has been reported to washout as fast as normal thyroid tissue (“rapid washout”) which may lead to diagnostic failure. We aimed to evaluate the determinants of rapid washout and to determine the role of subtraction imaging for detection of parathyroid adenomas/hyperplasia with rapid washout.
Retrospective analysis of patients with hyperparathyroidism who have undergone Tc99m-sestamibi dual-time imaging and parathyroid surgery. Rapid washout was correlated to the type of hyperparathyroidism in surgically confirmed cases. Biochemical and pathological data were reviewed.
A total of 135 hyperparathyroidism patients met the inclusion criteria. Ninety-six (72%), 29 (21%), and 10 (7%) had primary, secondary, and tertiary hyperparathyroidisms, respectively. Rapid washout was identified in 28/87 glands (32%), 14/53 glands (26%), and 1/16 glands (6%) with primary, secondary, and tertiary hyperparathyroidisms, respectively. Glands that were positive on late-phase Tc99m-sestamibi scans were significantly large being 1.7 (IQR 1.4–2.3) vs. 1.45 (IQR 1–2) cm (p = 0.003). High parathyroid hormone levels (PTH) were associated with early-phase Tc99m-sestamibi positivity in both primary (p = 0.01) and secondary hyperparathyroidism (p = 0.03) but not with last phase (p = 0.11, p = 0.37, respectively). Correlative imaging with subtraction scintigraphy was positive in 14/16 (87.5%) parathyroid adenomas.
Pre-operative PTH levels and size of the gland were major determinants of Tc99m-sestamibi positivity on early-phase Tc99m-sestamibi scans, whereas size is an independent predictor of late-phase Tc99m-sestamibi positivity. Subtraction scintigraphy might be a useful tool in suspected cases of rapid washout adenomas/hyperplasia.
KeywordsHyperparathyroidism Parathyroid adenomas Rapid washout PTH
The work was presented as a poster at Endocrine Society’s annual meeting proceedings 2017, Orlando, FL.
Compliance with ethical standards
The corresponding author’s (K.K) institutional review board approved the study.
Conflict of interest
- 1.Michaud L, Balogova S, Burgess A, Ohnona J, Huchet V, Kerrou K, Lefèvre M, Tassart M, Montravers F, Périé S, Talbot J-N (2015) A pilot comparison of (18)F-fluorocholine PET/CT, ultrasonography and (123)I/(99m)Tc-sestaMIBI dual-phase dual-isotope scintigraphy in the preoperative localization of hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism: influence of thyroid anomalies. Medicine 94(41):e1701. https://doi.org/10.1097/MD.0000000000001701 CrossRefGoogle Scholar
- 3.Kluijfhout WP, Vorselaars WM, Vriens MR, Borel Rinkes IH, Valk GD, de Keizer B (2015) Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT. Eur J Radiol 84(9):1745–1751. https://doi.org/10.1016/j.ejrad.2015.05.024 CrossRefGoogle Scholar
- 6.Caveny SA, Klingensmith WC 3rd, Martin WE, Sage-El A, McIntyre RC Jr, Raeburn C, Wolfe P (2012) Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I. J Nucl Med Technol 40(2):104–110. https://doi.org/10.2967/jnmt.111.098400 CrossRefGoogle Scholar
- 9.Chen CC, Holder LE, Scovill WA, Tehan AM, Gann DS (1997) Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. J Nucl Med 38(6):834–839Google Scholar
- 11.Omar WS, Eissa S, Moustafa H, Farag H, Ezzat I, Abdel-Dayem HM (1997) Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrite (sestaMIBI) in evaluation of breast masses: correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions. Anticancer Res 17(3B):1639–1644Google Scholar
- 12.Neumann DR, Esselstyn CB, Maclntyre WJ, Go RT, Obuchowski NA, Chen EQ, Licata AA (1996) Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med 37(11):1809–1815Google Scholar
- 13.Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P (2003) Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 44(6):904–908Google Scholar
- 14.Arveschoug AK, Bertelsen H, Vammen B, Brochner-Mortensen J (2007) Preoperative dual-phase parathyroid imaging with tc-99m-sestamibi: accuracy and reproducibility of the pinhole collimator with and without oblique images. Clin Nucl Med 32(1):9–12. https://doi.org/10.1097/01.rlu.0000249401.48030.9c CrossRefGoogle Scholar
- 19.Sandrock D, Merino MJ, Norton JA, Neumann RD (1993) Ultrastructural histology correlates with results of thallium-201/technetium-99m parathyroid subtraction scintigraphy. J Nucl Med 34(1):24–29Google Scholar
- 20.Benard F, Lefebvre B, Beuvon F, Langlois MF, Bisson G (1995) Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma. J Nucl Med 36(2):241–243Google Scholar
- 22.Pons F, Torregrosa JV, Fuster D (2003) Biological factors influencing parathyroid localization. Nucl Med Commun 24(2):121–124. https://doi.org/10.1097/01.mnm.0000057324.59072.67 CrossRefGoogle Scholar
- 25.Hung GU, Wang SJ, Lin WY (2003) Tc-99m MIBI parathyroid scintigraphy and intact parathyroid hormone levels in hyperparathyroidism. Clin Nucl Med 28(3):180–185. https://doi.org/10.1097/01.RLU.0000053529.71776.37 Google Scholar
- 27.Staudenherz A, Abela C, Niederle B, Steiner E, Helbich T, Puig S, Kaserer K, Becherer A, Leitha T, Kletter K (1997) Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 24(2):143–149CrossRefGoogle Scholar
- 29.Carpentier A, Jeannotte S, Verreault J, Lefebvre B, Bisson G, Mongeau CJ, Maheux P (1998) Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. J Nucl Med 39(8):1441–1444Google Scholar
- 31.Hassler S, Ben-Sellem D, Hubele F, Constantinesco A, Goetz C (2014) Dual-isotope 99mTc-MIBI/123I parathyroid scintigraphy in primary hyperparathyroidism: comparison of subtraction SPECT/CT and pinhole planar scan. Clin Nucl Med 39(1):32–36. https://doi.org/10.1097/RLU.0000000000000272 CrossRefGoogle Scholar
- 32.Hindie E, Melliere D, Jeanguillaume C, Perlemuter L, Chehade F, Galle P (1998) Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123. J Nucl Med 39(6):1100–1105Google Scholar
- 33.Neumann DR, Esselstyn CB Jr, Madera A, Wong CO, Lieber M (1998) Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography. J Clin Endocrinol Metab 83(11):3867–3871. https://doi.org/10.1210/jcem.83.11.5241 CrossRefGoogle Scholar